Rabies Treatment Market 2018 Top Players Analysis | Sanofi (France), Pfizer (U.S.), Bavarian Nordic (U.S.), Solvay (U.S.) and More

The Global Rabies Treatment Market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.

Rabies is a deadly virus that usually spreads from the saliva of infected/rabid animals. Animals that are most likely to transmit rabies include bats, raccoons, coyotes, foxes, and skunks. In developing countries, stray dogs are the most likely to get infected with rabies. It is stated by the WHO that rabies infection is responsible for tens of thousands of deaths every year, especially, in Asia and Africa.

Signs and symptoms of rabies include headache, nausea, vomiting, confusion, hyperactivity, difficulty in swallowing, agitation, anxiety, hallucinations, insomnia, partial paralysis, hydrophobia (fear of water), and excessive salivation. Rabies virus basically infects the central nervous system and salivary glands which ultimately leads to death. Treatment by vaccination is the best and most effective method in treating as well as preventing rabies. One of the approved and effective methods against rabies is when inactivated rabies vaccine is combined with rabies immunoglobulin. Rabies is diagnosed by detecting proteins present on the surface of rabies virus using samples of blood, saliva samples, and skin.

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/1629 .

To get rid of this deadly disease, various government, and privately held organizations actively participate to make people aware of the current scenario. For instance, the Food and Agriculture Organization (FAO), Global Alliance for Rabies Control (GARC), WHO, and International Organisation for Animal Health (OIE) teamed up together in 2015 to achieve strategic plan of "Zero human Rabies deaths by 2030". The main aim of this initiative is to prioritize healthcare investments in rabies control and coordinate the rabies-elimination efforts.

Key Players

Some of key the players in the rabies treatment market are

Sanofi (France),
Merck & Co. Inc.,
CSC Pharmaceuticals International
Pfizer (U.S.),
VBI Vaccines Inc. (U.S.),
Taj Pharmaceuticals Limited (India),
Bio Med Pvt. Ltd.,
Bavarian Nordic (U.S.),
Solvay (U.S.),
Informa plc. (U.S.)

Segmentation:

The rabies treatment market is segmented on the basis of type of rabies, type of treatment, and end users.

On the basis of type of rabies, market is segmented into furious rabies, paralytic rabies and others

On the basis of type of treatment, market is classified into rabies immunoglobin vaccine, bran tissue vaccine, tissue culture and others. On the basis of end-users, market is segmented into hospitals, clinics, epidemic prevention centres and others.

Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/1629 .

Brief TOC

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics

…TOC Continued

Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/1629 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.